BackCymabay Therapeutics Overview

Cymabay Therapeutics Operating Income

Operating Income for CBAY.

Quarterly Operating Income

$-42498000.00
↑ 81.02% YoY

As of Dec 31, 2023

Annual Operating Income (TTM)

$-101679000.00
↑ 9.2% YoY

Trailing 12 months ending Dec 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin